| Literature DB >> 35884117 |
Aniello Meoli1, Lorenzo Ciavola1, Sofia Rahman1, Marco Masetti1, Tommaso Toschetti1, Riccardo Morini1, Giulia Dal Canto1, Cinzia Auriti2, Caterina Caminiti3, Elio Castagnola4, Giorgio Conti5, Daniele Donà6, Luisa Galli7, Stefania La Grutta8, Laura Lancella9, Mario Lima10, Andrea Lo Vecchio11, Gloria Pelizzo12, Nicola Petrosillo13, Alessandro Simonini14, Elisabetta Venturini7, Fabio Caramelli15, Gaetano Domenico Gargiulo16, Enrico Sesenna17, Rossella Sgarzani18, Claudio Vicini19, Mino Zucchelli20, Fabio Mosca21, Annamaria Staiano11, Nicola Principi22, Susanna Esposito1.
Abstract
A surgical site infection (SSI) is an infection that occurs in the incision created by an invasive surgical procedure. Although most infections are treatable with antibiotics, SSIs remain a significant cause of morbidity and mortality after surgery and have a significant economic impact on health systems. Preventive measures are essential to decrease the incidence of SSIs and antibiotic abuse, but data in the literature regarding risk factors for SSIs in the pediatric age group are scarce, and current guidelines for the prevention of the risk of developing SSIs are mainly focused on the adult population. This document describes the current knowledge on risk factors for SSIs in neonates and children undergoing surgery and has the purpose of providing guidance to health care professionals for the prevention of SSIs in this population. Our aim is to consider the possible non-pharmacological measures that can be adopted to prevent SSIs. To our knowledge, this is the first study to provide recommendations based on a careful review of the available scientific evidence for the non-pharmacological prevention of SSIs in neonates and children. The specific scenarios developed are intended to guide the healthcare professional in practice to ensure standardized management of the neonatal and pediatric patients, decrease the incidence of SSIs and reduce antibiotic abuse.Entities:
Keywords: neonatal infection; pediatric infectious diseases; pediatric surgery; prevention; surgical site infection
Year: 2022 PMID: 35884117 PMCID: PMC9311619 DOI: 10.3390/antibiotics11070863
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
SSI rates in children and neonates.
| Study | Type of Study | (N of Patients) Study Population | SSI Rate | Type of Surgery |
|---|---|---|---|---|
| Murray, 2014 [ | Single-center, retrospective | (470) 0–1 y.o., postoperative | 3.4% (6.8 in neonates) | Cardiac surgery |
| Lejus, 2013 [ | Single-center, retrospective | (286) neonates, postoperative | 3.8% | Non-specified |
| Zingg, 2017 [ | Multicenter, retrospective | (17,273) 0–18 y.o., all patients | 0.18% | Non-specified |
| Boomer, 2014 [ | Single-center, retrospective | (1388) 0–18 y.o., postoperative | 5.1% | Appendicectomy |
| Katayanagi, 2015 [ | Single-center, retrospective | (174) 0–15 y.o., postoperative | 17% and 6.9% ** (superficial SSI) | Cardiac surgery |
| Clements, 2016 [ | Single-center, retrospective | (165) neonates, postoperative | 11.7% | Non-specified |
| Prasad, 2016 [ | Multicenter, retrospective | (902) neonates, postoperative | 4.46% | Non-specified |
| Kulaylat, 2018 [ | Multicenter, retrospective | (129,849) 0–18 y.o., postoperative | 0.9% | Non-specified |
| Blackwood *, 2017 [ | Multicenter, retrospective | (66,671) 2–18 y.o., postoperative | 2% | Non-specified |
| Blackwood *, 2017 [ | Multicenter, retrospective | 2–18 y.o., postoperative | 3.6% | Paediatric general surgery |
| Blackwood *, 2017 [ | Multicenter, retrospective | 2–18 y.o., postoperative | 2.5% | Cardiothoracic surgery |
| Blackwood *, 2017 [ | Multicenter, retrospective | 2–18 y.o., postoperative | 2.4% | Paediatric neurosurgery |
| Inoue, 2018 [ | Single-center, retrospective | (181) neonates, postoperative | 8.8% | Non-specified |
| Bartz-Kurycki, 2018 [ | Multicenter, retrospective | (3589) neonates, postoperative | 4% | Non-specified |
| Malik, 2019 [ | Multicenter, retrospective | (1891) 2–18 y.o., postoperative | 4.2% | Posterior spinal fusion |
| Li, 2019 [ | Single-center, retrospective | (18,314) 0–18 y.o., postoperative | 0.9% | Non-specified |
| Canadian Nosocomial Infection Surveillance Program, 2020 [ | Multicenter, retrospective | (266) 0–18 y.o., postoperative | 3.3% | Paediatric neurosurgery |
| Canadian Nosocomial Infection Surveillance Program, 2020 [ | Multicenter, retrospective | 0–18 y.o., postoperative | 4.1% | Cardiac surgery |
| Woodward, 2020 [ | Multicenter, retrospective | (807) 0–18 y.o., postoperative | 2.4% (superficial SSI) | Cardiac surgery |
| Shibamura-Fujiogi, 2020 [ | Single-center, retrospective | (621) 0–18 y.o., postoperative | 6.3% | Intestinal surgery |
| Pough, 2020 [ | Single-center, retrospective | (192) 0–18 y.o., postoperative | 6% | Colo-rectal surgery |
| Tipper, 2019 [ | Single-center, prospective | (355) 2.5–17.9 y.o., postoperative | 1.9% and 2.5% (idiopathic and neuromuscular scoliosis, respectively) | Spinal surgery |
| Furdock, 2020 [ | Multicenter, retrospective | (111) 8–20 y.o., postoperative | 6.3% | Spinal surgery |
* This study both reported overall SSI rates and subspecialty-specific SSI rates. ** Before and after the implementation of new prevention strategies.
Risk factors for SSIs in children and neonates.
| Study | (N of Patients) Population | Risk Factors Identified |
|---|---|---|
| Li, 2019 [ | (18,314) 0–18 y.o. | Type of surgery |
| Blackwood, 2017 [ | (66,671) 2–18 y.o. | Type of surgery |
| Elward, 2015 [ | (19) 0–18 y.o. | Longer procedure and previous surgery (for craniostomy), longer time at lowest body temperature, postoperative anticoagulants (for spinal fusion) |
| Woodward, 2020 [ | (807) 0–18 y.o. | Delayed sternal closure, type of surgical wound dressing |
| Sochet, 2017 [ | (12) 0–18 y.o. | length of stay at the hospital, post-surgical thoracostomy output, peak fluid overload, IV fluids/blood products administered volume |
| Katayanagi, 2015 [ | (174) 0–15 y.o. | Length of hospitalization, MRSA colonization, duration of surgery, lowest rectal temperature, cardiac bypass circuit volume, blood transfusion volume |
| Murray, 2014 [ | (470) 0–1 y.o. | Neonatal age, higher postoperative glycaemia, blood loss |
| Pough, 2020 [ | (192) 0–18 y.o. | Emergent surgery, length of surgery, hyperglycaemia |
| Costello, 2010 [ | (67) 0–18 y.o. | Age < 1 y, longer duration of cardiopulmonary bypass, >2RBC transfusions |
| Shibamura-Fujiogi, 2020 [ | (621) 0–18 y.o. | Higher dose of volatile anaesthetics |
| Boomer, 2014 [ | (1388) 0–18 y.o. | Older age, gastrointestinal comorbidity, open operation (or laparoscopic operation converted to an open operation), longer length of symptoms |
| Butler, 2020 [ | (720), 0–18 y.o. | Laparotomy |
| Tipper, 2019 [ | (355) 2.5–17.9 y.o. | Neuromuscular scoliosis |
| Furdock, 2020 [ | (111), 8–20 y.o. | Higher Hct and Hb |
| Malik, 2019 [ | (1291), 2–18 y.o. | Obesity |
| Inoue, 2018 [ | (181), neonates | MRSA colonization |
| Bartz-Kurycki, 2018 [ | (3589), neonates | Length of stay at the hospital, nutritional support, contamination of the surgical wound, preoperative transfusions, preoperative dialysis, lower GA, longer operative duration, low weight at surgery, CNS abnormalities |
| Clements, 2016 [ | (165) neonates, postoperative | Duration of procedure, type of surgery |
| Prasad, 2016 [ | (902) neonates | Lower GA and CA |
| Lejus, 2013 [ | (286) neonates | Lower GA, length of stay at the hospital |
* Reported risk factors only apply to complicated appendicitis. GA: gestational age, CA: chronological age.
Most frequent pathogens involved in pediatric and neonatal SSIs.
| Study | N of Patients with SSI | Kind of Surgery | Most Common Bacteria Detected 1 |
|---|---|---|---|
| CNISP, 2020 [ | 190 | Cardiac surgery | |
| Shibamura-Fujiogi, 2020 [ | 39 (42 positive cultures gathered, 22 for superficial SSI and 20 for Deep/Organ space SSI)) | Intestinal surgery | Superficial SSI: Enterococci (27%), |
| Deep/Organ space SSI: Enterococci (30%), | |||
| Pough, 2020 [ | 12 | Gastrointestinal surgery | MRSA alone 17%, |
| Tipper, 2019 [ | 9 3 | Scoliosis surgery | |
| Furdock, 2020 [ | 7 | Neuromuscular scoliosis surgery | Polimicrobial (42%), MSSA alone (28%), MRSA alone (14%), unassessed (14%) |
| Weiner-Lastinger, 2020 [ | 2215 3 | Abdominal surgery | |
| 487 3 | Orthopedic surgery | ||
| 419 3 | Neurosurgical surgery | ||
| 312 3 | Cardiac surgery | ||
| Lake, 2018 [ | 3053 3 | Any kind of surgery | |
| Woltmann, 2017 [ | 212 3 (from 2012 to 2015) | Clean or clean-contaminated surgery | MSSA (27%), MRSA (15%), CoNS (14%), |
| 286 3 (from 2006 to 2011) | MSSA (28%), MRSA (12%), CoNS (12%), | ||
| 420 3 (from 2000 to 2005) | CoNS (25%), MSSA (15%), | ||
| 323 3 (from 1994 to 1999) | MSSA (17%), CoNS (16%), | ||
| Prasad, 2016 [ | 26 4 | Any kind of surgery on neonates | |
| Lejus, 2013 [ | 11 | Any kind of surgery on neonates | MRCoNS (63%), MSSA (18%), MSCoNS (9%), |
1 Some patients had cultures positive for more than one bacteria species. 2 The prevalence of the 6 most frequent species overall were reported. 3 Number of SSIs reported (specified when it differs from the number of patients in which SSIs were identified or when the number of patients was not specified in the study). 4 Only 26 cultures were obtained out of the 60 SSIs reported by the study. MSSA: methicillin-susceptible S. aureus; MRSA: methicillin-resistant S. aureus; CoNS: Coagulase-negative Staphylococci (MRCoNS and MSCoNS: methicillin-resistant and sensitive, respectively).
Most common ventilation systems in the operating room.
| Ventilation System | Description |
|---|---|
| Natural ventilation | The most basic way to ventilate an environment. Use of natural forces to introduce and distribute outdoor air into or out of a building. This kind of ventilation might be used in settings with limited resources, even if there is no evidence for its use in operating rooms |
| Conventional airflow (turbulent flow) | This system uses variably filtered air introduced via ceiling diffusers. The air is then removed via pressure dampers at floor level. |
| Laminar airflow (unidirectional flow) | This mechanism requires the installation of filters supplying clean air through high-efficiency particulate air (HEPA) filters. The filtered air moves from the operative field to the exhaust grill. This system can change the air up to 300 times per hour. In an ideal situation, this system is associated with a lower concentration of microorganisms when compared to conventional airflow, but in everyday practice, its efficiency is reduced due to different factors (i.e., the position of the surgeons, sterility of instruments, etc.). |
| Negative pressure environment | This system is mainly used in order to reduce the release of infective particles to nearby spaces, sealing all doors and installing exhaust fans. This technique was highly recommended during the COVID-19 pandemic. In fact, even with low evidence, it is believed to reduce the risk of infection in the operators. |